Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-063926
Filing Date
2021-11-10
Accepted
2021-11-10 17:53:36
Documents
1
Period of Report
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3921
  Complete submission text file 0001209191-21-063926.txt   5343
Mailing Address C/O AMUNIX PHARMACEUTICALS, INC. 2 TOWER PLACE, #1100 SOUTH SAN FRANCISCO CA 94080
Business Address
You Angie (Reporting) CIK: 0001647664 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 211398110

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations